These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 16304961)

  • 21. [Alternative approaches to ovarian stimulation].
    Alvarez S
    Gynecol Obstet Fertil; 2007 Sep; 35(9):885-9. PubMed ID: 17825596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment.
    Devroey P; Aboulghar M; Garcia-Velasco J; Griesinger G; Humaidan P; Kolibianakis E; Ledger W; Tomás C; Fauser BC
    Hum Reprod; 2009 Apr; 24(4):764-74. PubMed ID: 19153090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GnRH agonists vs antagonists.
    Tarlatzis BC; Kolibianakis EM
    Best Pract Res Clin Obstet Gynaecol; 2007 Feb; 21(1):57-65. PubMed ID: 17049460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity.
    Orvieto R; Meltzer S; Rabinson J; Zohav E; Anteby EY; Nahum R
    Fertil Steril; 2008 Oct; 90(4):1294-6. PubMed ID: 18178197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GnRH agonist long protocol vs. a single 3-mg gnRH antagonist: a comparison of 2 protocols for pituitary down-regulation in oocyte donor-controlled ovarian hyperstimulation cycles.
    Erb TM; Wakim AN
    J Reprod Med; 2008 May; 53(5):331-7. PubMed ID: 18567278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Appropriate methods to monitor controlled ovarian hyperstimulation?
    Cebesoy FB
    Fertil Steril; 2008 Apr; 89(4):1025; author reply 1025-6. PubMed ID: 18325501
    [No Abstract]   [Full Text] [Related]  

  • 27. Gonadotropin-releasing hormone-induced ovulation and luteinizing hormone release in beef heifers: effect of day of the cycle.
    Atkins JA; Busch DC; Bader JF; Keisler DH; Patterson DJ; Lucy MC; Smith MF
    J Anim Sci; 2008 Jan; 86(1):83-93. PubMed ID: 17911234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ISMAAR proposal on terminology for ovarian stimulation for IVF.
    Nargund G; Fauser BC; Macklon NS; Ombelet W; Nygren K; Frydman R;
    Hum Reprod; 2007 Nov; 22(11):2801-4. PubMed ID: 17855409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GnRH agonist versus GnRH antagonist in ovarian stimulation: the influence of body mass index on in vitro fertilization outcome.
    Rabinson J; Meltcer S; Zohav E; Gemer O; Anteby EY; Orvieto R
    Fertil Steril; 2008 Feb; 89(2):472-4. PubMed ID: 17582402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gonadotropin-releasing hormone (GnRH) and its natural analogues: a review.
    Schneider F; Tomek W; Gründker C
    Theriogenology; 2006 Sep; 66(4):691-709. PubMed ID: 16650469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of protocols efficacy in poor responders: differences in oocytes/embryos competence with different protocols, a retrospective study.
    Manno M; Tomei F; Cervi M; Favretti C; Adamo V
    Fertil Steril; 2009 Apr; 91(4 Suppl):1431-3. PubMed ID: 18706554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial distribution and activity in human mature oocytes: gonadotropin-releasing hormone agonist versus antagonist for pituitary down-regulation.
    Dell'Aquila ME; Ambruosi B; De Santis T; Cho YS
    Fertil Steril; 2009 Jan; 91(1):249-55. PubMed ID: 18367183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does day 3 luteinizing-hormone level predict IVF success in patients undergoing controlled ovarian stimulation with GnRH analogues?
    Orvieto R; Meltzer S; Rabinson J; Gemer O; Anteby EY; Nahum R
    Fertil Steril; 2008 Oct; 90(4):1297-300. PubMed ID: 18249369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of gonadorelin products in lactating dairy cows: efficacy based on induction of ovulation of an accessory follicle and circulating luteinizing hormone profiles.
    Souza AH; Cunha AP; Silva EP; Gümen A; Ayres H; Guenther JN; Wiltbank MC
    Theriogenology; 2009 Jul; 72(2):271-9. PubMed ID: 19394072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GnRH agonist and GnRH antagonist in intracytoplasmic injection cycles.
    Rashid MR; Ong FB; Omar MH; Ng SP; Nurshaireen A; Sharifah-Teh NS; Fazilah AH; Zamzarina MA
    Med J Malaysia; 2008 Jun; 63(2):113-7. PubMed ID: 18942295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gonadotropin-releasing hormone agonist/antagonist conversion with estrogen priming in low responders with prior in vitro fertilization failure.
    Fisch JD; Keskintepe L; Sher G
    Fertil Steril; 2008 Feb; 89(2):342-7. PubMed ID: 17562336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expanding role of recombinant gonadotropins in assisted reproduction.
    Adams TE; Boime I
    Reprod Domest Anim; 2008 Jul; 43 Suppl 2():186-92. PubMed ID: 18638122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substituting human chorionic gonadotropin by gonadotropin-releasing hormone agonist to trigger final follicular maturation, during controlled ovarian hyperstimulation, results in less systemic inflammation.
    Orvieto R; Zagatsky I; Yulzari-Roll V; La Marca A; Fisch B
    Gynecol Endocrinol; 2006 Aug; 22(8):437-40. PubMed ID: 17012105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug delivery for in vitro fertilization: rationale, current strategies and challenges.
    Janát-Amsbury MM; Gupta KM; Kablitz CD; Peterson CM
    Adv Drug Deliv Rev; 2009 Aug; 61(10):871-82. PubMed ID: 19426774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poor responder protocols for in-vitro fertilization: options and results.
    Loutradis D; Vomvolaki E; Drakakis P
    Curr Opin Obstet Gynecol; 2008 Aug; 20(4):374-8. PubMed ID: 18660689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.